Introduction
Neurosurgical intervention in patients with idiopath ic thrombocytopenic purpura (ITP) is rare because intraoperative bleeding is difficult to control.
Three of eight reported operations on ITP patients with intracranial hematoma resulted in peri or postoperative death."' Control of the hemorrhagic diathesis in ITP patients is most important to achieve satisfactory results.
We report the successful clipping of a ruptured cerebral aneurysm in an ITP patient after preoperative high-dose gamma-globulin therapy. The effectiveness of this therapy and the approach to such patients are discussed. (Fig. 2) . The platelet count was 4.4 x 10'/mm' and bleeding time was 14.5 minutes (Table 1) . High-dose gamma globulin infusion therapy (20 gm/day for 5 days) was given to rapidly increase the platelet count in prepara tion for surgery (Fig. 3) . The platelet count increased to 7.9 x 104 and the bleeding time decreased to 5 minutes on October 9. However, 30% of the platelets were large enough to be equivalent to two small platelets. Therefore, the actual equivalent platelet count was 10.3 x 104. The aneurysmal neck was clip ped on October 9 with 500 ml estimated blood loss.
Postoperative course was uneventful and the platelet count remained at more than 10 x 104 until October 20.
Follow-up cerebral angiography demonstrated the clipped aneurysm and a mild cerebral arterial spasm (Fig. 4) . She was discharged without neurological deficits on October 31, 1989.
She received a splenectomy on March 1, 1990 to decrease the required steroid dosage after preope rative high-dose gamma-globulin therapy. However, her platelet count was only 8 x 104 on April 11, 1990.
Her platelet count gradually increased with 15 mg prednisolone up to 31.3 x 104 in August 1990, and thereafter ranged from 9 to 22.7 x 104 with 10-15 mg of prednisolone. Our patient later received splenectomy, but the platelet count did not increase adequately. Platelet transfusion will increase the platelet count but the effect is temporary and results in formation of an tiplatelet antibodies. Cerebral aneurysm, as in our case, does not always require immediate surgery unlike intracranial hemor rhage with cerebral herniation,5) so the operation can be delayed until the hemorrhagic diathesis can be controlled.
Imbach et a1.4) introduced high-dose gamma globulin therapy (400 mg/kg/day for 5 days) in 1981. The resultant platelet count increase was adequate to tolerate surgery within a few days and remained effective for about a week. Gamma globulin operates by 1) overloading the reticuloen dothelial system to reduce platelet destruction, and 2) inhibition of antiplatelet antibody binding to the platelets.
Our patient's neurological condition was good and the cause of bleeding was a ruptured intracranial aneurysm, not hemorrhagic diathesis. We therefore selected high-dose gamma-globulin therapy followed by delayed aneurysm clipping.
No cases of cerebral aneurysm associated with ITP have previously been reported. We believe that the association of cerebral aneurysm and ITP was in cidental in this case. The management of ITP pa tients with ruptured cerebral aneurysm has never been discussed. We recommend preoperative high dose gamma-globulin therapy with or without steroid and/or platelet transfusion followed by delayed surgery after the hemorrhagic diathesis is completely controlled. 11: 111-116, 1986 (in Japanese) 
